Evidence mapPaperPMID 41214786Full record

ArticleJournal of ovarian research2025

MMP-9 dysregulation and chronic inflammation in polycystic ovary syndrome: linking ovulatory dysfunction to diagnostic implications.

Li Wang, Dongsheng Xiong, Heqiu Yan, Fangyi Long, Guohui Zhang, Jiuzhi Zeng, Jun Liu, Qin Zeng, Yanan Zhang, Xia Bai and 2 more

Abstract read
In one paragraph

Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Li Wang *Reproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Dongsheng Xiong *Reproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Heqiu YanReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Fangyi LongLaboratory Medicine Center, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Guohui ZhangReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Jiuzhi ZengReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Jun LiuReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Qin ZengReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Yanan ZhangReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Xia BaiReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China.
Mengjun LuoDepartment of Clinical Laboratory, School of Medicine, Chengdu Women's and Children's Central Hospital, University of Electronic Science and Technology of China, No.1617 Ri Yue Street, Chengdu, Sichuan, 611731, China. luomengjun2023@163.com.
Weixin LiuReproductive Medicine Center, Key Laboratory of Reproductive Medicine, Sichuan Provincial Woman's and Children's Hospital, the Affiliated Women's and Children's Hospital of Chengdu Medical College, Chengdu, Sichuan, 610045, China. liuweixind@163.com.

Funding

Chengdu Medical College research project CYZYB23-03Sichuan Natural Science Foundation project 24NSFSC1674Sichuan Provincial Science and Technology Department Central Guidance Local Science and Technology Development Project 2024ZYD0067Sichuan Women's and Children's Hospital Science and technology innovation fund project 20240101
6 · The paper itself

Abstract

backgroundDysregulation of matrix metalloproteinase 9 (MMP-9) and chronic low-grade inflammation have been implicated ovulatory dysfunction in polycystic ovary syndrome (PCOS), yet their roles remain inadequately addressed in clinical practice. This study aimed to investigate the interrelationships and functional roles of inflammation, hormone, and the MMP-9/TIMP-1 system in PCOS.

methodA PCOS rat model was established to evaluate serum hormone levels, inflammatory markers, and MMP-9/TIMP-1 levels. Ovarian expression of IL-6 and MMP-9 was examined using Immunohistochemistry and immunofluorescence. Additionally, a cohort study comprising 83 PCOS patients and 97 healthy controls was analyzed to evaluate serum hormonal and inflammatory profiles, with further assessment of their associations with PCOS and predictive value.

resultIn the PCOS rat model, marked disruptions in serum lipid and hormone profiles were observed, accompanied by elevated levels of IL-6 and MMP-9. Histological examination of ovarian tissues showed an increased number of atretic follicles and enhanced expression of both IL-6 and MMP-9. In the clinical cohort, patients with PCOS showed significantly higher levels of TSTO, LH and IL-6 compared to controls. Although MMP-9 and TIMP-1 levels were both elevated, the MMP9/TIMP1 ratio remained unchanged. Correlation analysis indicated positive associations between IL-6, TNF-α, MMP-9, TIMP-1, and PCOS. Logistic regression identified TSTO, FSH, and IL-6 as independent risk factors, with ROC analysis further highlighting IL-6 as the most robust predictor for PCOS.

conclusionThis study demonstrates that systemic inflammation and hormonal disturbances are closely linked to PCOS. In PCOS patients, particular attention should be given to elevated levels of inflammatory factors such as IL-6 and dysregulated of the immune microenvironment, which play critical roles in the pathogenesis of the disease. Further exploration of the potential application of targeted inflammatory management in clinical intervention strategies is warranted.

Indexed as

InflammationMatrix Metalloproteinase 9OvulationPolycystic Ovary SyndromeAdultAnimalsBiomarkersCase-Control StudiesDisease Models, AnimalFemaleHumansInterleukin-6OvaryRatsTissue Inhibitor of Metalloproteinase-1Young AdultBiomarkersInterleukin-6Matrix Metalloproteinase 9TIMP1 protein, humanTissue Inhibitor of Metalloproteinase-1InflammationMMP-9Ovarian dysfunctionPCOS

Identifiers

PMID41214786
PMCPMC12604328

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.